translation agency

CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update
LOUISIANA: Louisiana State University Health Sciences Center Gets About $9 Million to Develop Pneumonia Vaccine

October 26, 2011
Associated Press (10.23.11) - Wednesday, October 26, 2011

The National Heart, Lung, and Blood Institute, part of the National Institutes of Health, has awarded an LSU doctor a five-year grant of about $9 million to support work to develop a vaccine against a major cause of pneumonia in HIV-positive people. Dr. Judd Shellito of LSUHSC-New Orleans said pneumocystitis is the most common severe secondary infection for people living with HIV. The fungus that causes the condition is not affected by current antifungal drugs; it also strikes others whose immune systems are compromised, such as cancer patients and transplant recipients.